Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 17 of 17

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Time to Sustained Recovery in Days	Up to 28 days	Participants with sustained recovery.	days	MEDIAN
PRIMARY	Number of Participants With Hospitalization or Death	Up to 28 days		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Number of Participants With Mortality	Up to 28 days		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Time to Mortality	Up to 28 days	Data not collected due to no participants having mortality.
SECONDARY	Number of Participants With Hospitalization, Urgent Care, Emergency Room Visit, or Death	Up to 28 days		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7	Day 7	Participants with COVID clinical progression scale data available.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 14	Day 14	Participants who had COVID clinical progression scale data available.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 28	Day 28	Participants who had COVID clinical progression scale data available.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Physical Function	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Fatigue	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Pain	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Depression	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Anxiety	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Social	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Quality of Life (QOL) as Measured by the PROMIS-29 - Sleep	Day 7, 14, 28, 90, 120, and 180	Participants with data collected at each timepoint.	score on a scale	MEDIAN
SECONDARY	Time Unwell in Days as Measured by the Symptom and Clinical Event Scale	Up to 14 days	Participants with time unwell.	days	MEAN
SECONDARY	Mean Days Benefit as Measured by the Symptom and Clinical Event Scale	Up to 14 days	Participants with time unwell.	days	MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06042855/outcomes

API reference For AI assistants